Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Clinical trial NCT02334254 · UNKNOWN
Trial details
- NCT number
- NCT02334254
- Sponsor
- Beijing Anzhen Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-01-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.